- KR₩22bn
- KR₩20bn
- KR₩52bn
Brief: Seoul Pharma appoints CEO
Brief: Seoul Pharma issues 3rd tranche convertible bonds worth 6 bln won
Brief: Seoul Pharma signs contract worth 7.86 bln won
Brief: Seoul Pharma signs contract worth 8.62 bln won
Brief: Seoul Pharma signs contract worth 111.08 bln won
Brief: Seoul Pharma to pay annual dividend as 15 won/share for FY 2016
Brief: Seoul Pharma signs 3.76 bln won contract with Darou Gostar Tadbir Nikan